Current filters:


7950 to 7959 of 96112 results

Setback for Gilead’s oral hep C drug candidate


There was disappointment for US biotech firm Gilead Sciences (Nasdaq: GILD) last Friday, when the company…

Anti-viralsBiotechnologyGilead SciencesResearch

uniQure to acquire Amsterdam Molecular Therapeutics business


Netherlands-based human gene based therapies developer Amsterdam Molecular Therapeutics (Euronext: AMT)…

Amsterdam MolecularBiotechnologyMergers & AcquisitionsuniQure

Pfizer and Hisun flesh-out plans for generics JV in China


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Vivo Ventures raises $375 million to invest in health care in USA and China


Vivo Ventures, a health care investment firm with offices in Palo Alto, California, Shanghai, and Chengdu,…

Asia-PacificFinancialHealthcareNorth AmericaPharmaceutical

Four new drugs will change prostate cancer care, says US expert


After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer…

AlgetaAlpharadinAmgenBavarian NordicBayerJohnson & JohnsonOncologyPharmaceuticalProstvacXgevaZytiga

7950 to 7959 of 96112 results

Back to top